“…They include local reactions at the site of injection, specific cutaneous disorders and nonspecific maculopapular eruptions. Localized reactions at the site of injection are characterized by urticarial wheals with edema although lichenoid reactions have also been described [8,9,10]. Development of neutrophilic dermatoses such as Sweet’s syndrome [11,12,13], pyoderma gangrenosum [14, 15], neutrophilic eccrine hidradenitis [16], leukocytoclastic vasculitis [17,18,19] and folliculitis [20] have occasionally been reported.…”